Evidence map›Paper›PMID 40548443›Full record

ArticleItalian journal of food safety2025

Accelerated shelf-life assessment of moringa-fortified instant complementary food for infants aged 6-11 months based on microbial parameters.

Zakaria Zakaria, Nursalim Nursalim, Andi Toewo Titi Za

Abstract read
In one paragraph

Article in Italian journal of food safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zakaria ZakariaDepartment of Nutrition, Makassar Health Polytechnic of the Ministry of Health, Makassar.
Nursalim NursalimDepartment of Nutrition, Makassar Health Polytechnic of the Ministry of Health, Makassar.
Andi Toewo Titi ZaDepartment of Nutrition, Makassar Health Polytechnic of the Ministry of Health, Makassar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Instant powdered complementary food is a commercial product designed to meet the nutritional needs of infants aged 6-11 months. This study aimed to determine the shelf life of instant powdered complementary food products fortified with moringa flour using semi-aluminum foil packaging based on microbial and mold growth parameters. The product was prepared from a mixture of ingredients such as wheat flour, mocaf flour, soybean flour, chicken eggs, ultra-high temperature milk, and vegetable oil, according to the SNI 01-7111.1-2005 standards. The study used the accelerated shelf-life testing method with the Arrhenius equation model, storing the products at 30°C, 40°C, and 50°C for 28 days. Results showed that total microbial and mold counts increased significantly at 30°C and 40°C over 28 days, while storage at 50°C led to a decline in microbial counts and slower mold growth. Using the Arrhenius-based first-order model, the predicted shelf life increased with temperature, reaching up to 92.7 days based on microbial growth and 40.8 days based on mold growth at 50°C. This trend is attributed to the lower reaction rate constants (k values) at higher temperatures, indicating slower deterioration. However, since mold growth was the limiting factor, the shortest shelf-life estimate, 33.5 days at 30°C, should be considered for practical labeling. It is therefore recommended to store moringa-fortified instant complementary food packaged in semi-aluminum foil at or below 30°C to suppress microbial activity and maintain product safety and quality throughout its shelf life. These results highlight the importance of temperature control in extending the product's microbial stability and suggest further real-time studies to validate shelf life under typical storage conditions.

Identifiers

PMID40548443
PMCPMC12451518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.